HEMK2 and pancreatic adenocarcinoma: Specifically, N6AMT1 was a protective factor for OS in PAAD patients (hazard ratio [HR] = 0.711, p = 0.025) and a risk factor for OS in PCPG patients (HR = 1.659, p = 0.020).